Matthew Fust

Biography

 Mr. Fust joined Dermira as a director in 2014. He is a board member and advisor to life sciences companies. Mr. Fust retired as Executive Vice President and Chief Financial Officer at Onyx Pharmaceuticals, where he served until its acquisition by Amgen. Prior to joining Onyx, he was Chief Financial Officer at Jazz Pharmaceuticals, Inc., Perlegen Sciences, Inc. and ALZA Corporation. Previously, he was a manager in the healthcare strategy practice at Andersen Consulting. Mr. Fust serves as a member of the board of directors of Atara Biotherapeutics, Inc., MacroGenics, Inc., Sunesis Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical, Inc.

Research Interest

 Dermatology